Sitemap

Technologies

• Pharmaceuticals
  • Use of miR-122* for Treating Cancer
  • TREATMENT OF ARDS ASSOCIATED WITH COVID-19
  • TARGETING NEUTROPHILS AS A THERAPY FOR SEVERE COVID-19 INFECTION
  • Supplementation Of Milk Formulas With Microvesicles Isolated From Milk
  • REPURPOSING OF FDA-APPROVED DRUGS FOR INHIBITING THE INFLAMMATORY PROCESS ASSOCIATED WITH CORONA VIRUS INFECTION
  • Protein X mutant as thrombolytic and coagulant agent‎
  • Protease Activated Receptors (PAR) Mimetics for Cancer Treatment.
  • Pluripotent Stem Cells, identical except for different Sex Chromosomes (XX vs. XY), and designed for drug development
  • Novel Targeted Therapy for Depression and Cancer
  • Novel synergic drug-combination for improved activation of the human mu opioid receptor ‎‎(MOR) with expected avoidance of drug-addiction ‎
  • Modulation of Myofibroblast Apoptosis for Treatment of Lung Fibrosis.
  • Method Of Selecting Cell Populations Enriched With Desired Cells.
  • Livin for formation of platelets
  • Inhibition of Ornithine Aminotransferase for Treatment of Hepatocellular Carcinoma.
  • Hepatoprotective effect of alpha 1 anti trypsin
  • Clinical Grade Embryonic Stem Cells for Multiple Indications
  • AN INHALED FORMULATION OF FDA-APPROVED DRUGS FOR TREATMENT OF ARDS
  
  
• Molecular Diagnostics
  • HIGH-THROUGHPUT TEST FOR SARS-COVID-2 VIRUS IN PATIENT SAMPLES
  • Erlotonib analogues for the noninvasive identification of EGFR tyrosine kinase inhibitor-responsive non-small cell lung carcinoma tumors using positron emission tomography
  
  
• Medical Devices
  • Optic Neuritis & Multiple Sclerosis Visual Tests
  • Non invasive aerosol free PAP ventilation
  • Icough - ACCUMULATIVE BREATH COUGHER
  • CT Perfusion Reference Phantom
  • Aortic Pacemaker
  
  
• Life Science & Biotech
  • Human Stem Cell-Derived Neural Precursors for Treatment of CNS Autoimmune Disease.
  • Allogeneic Tumor Cell Vaccination